The aim of this study was to present our experience of dealing with patients with phyllodes tumours (PT) and to correlate the risk of local recurrence with different clinicopathological factors.
Introduction
Phyllodes tumours (PT) are infrequent tumours occurring in the breast with an incidence of less than 1% of all breast tumours. 1 Though there are specific laid down criteria for diagnosing these cases, making a definite preoperative diagnosis is still difficult. Difficulty in making preoperative diagnoses and concern for uncertain clinical behaviour often results in inappropriate management of many patients with PT. 1, 2 One of the characteristic uncertainties about these tumours is the unpredictable risk of recurrence plaguing the clinical course of the disease. None of the clinicopathological factors have consistently been proven to be risk factors for recurrence and mortality so far. Surgery remains the mainstay of management, and the role of adjuvant therapy remains controversial. Recommended surgical options vary from wide local excision (WLE) to mastectomy. The majority of physicians currently suggest that irrespective of the pathology of PT (benign, borderline or malignant), WLE is an appropriate and adequate primary surgical intervention and a mastectomy is rarely required. [1] [2] [3] The aim of this study was to present our experience of dealing with patients with PT and to correlate the risk of local recurrence with different clinicopathological factors.
Materials and Methods
This was a retrospective study of 25 women with PT, who were managed between January 1991 and December 2006 at a tertiary referral centre in Northern India. In all included cases, histological diagnosis of PT was documented. All the demographic, clinical, investigational, operative and histology records were collected from the inpatient departmental database. Follow-up data were collected from the outpatient follow-up register and in a few cases by contacting patients by mail and telephone. WLE was when a tumour was excised with a minimum of a 1 cm margin from the palpable tumour. Simple local excision (LE) was when no attempt at WLE was made and margins were inadequate. Various clinicopathological features including the type of surgical intervention were compared between patients experiencing local recurrence to those not experiencing any recurrence. Statistical analysis was done using Student's t test, the Chi-square test, binary logistic regression and multivariate analysis on SPSS version 10 (SPSS Inc., Chicago, IL, USA). A p value of less than 0.05 was considered significant for all the tests.
Results
The mean age of the 25 patients was 45 ± 7 years (range, 20-75 years). The mean duration of having a lump was 30 ± 10 (2-240) months. All cases presented with large lump. The mean tumour diameter was 10 ± 5 (5-20) cm. One woman presented with bilateral PT. Two patients had ulcers overlying the lump. Palpable axillary lymph nodes were present in seven cases. Out of the 25 cases, 19 (76%) patients presented with primary disease and six (24%) patients presented after experiencing recurrence.
Three cases reported to us after experiencing more than one recurrence. The primary surgical procedures in recurrent cases were mostly performed at peripheral hospitals and since fine needle aspiration cytology (FNAC) was not available at most of these peripheral hospitals, the attending surgeon performed operations as though these were fibroadenoma and a diagnosis of PT could not be made in the preoperative period. The reported final histological diagnosis in these six cases were: one fibroadenoma, one fibroadenosis, one giant fibroadenoma, two epithelial hyperplasia, and one PT (malignant potential not specified). No tissue or slides were available for review. The three recurrent patients initially operated on at our centre were reported as having giant fibroadenoma in one case and benign PT in the other two cases. All patients were subsequently subjected to FNAC. Preoperative diagnosis of PT could be made in 18 (72%) cases. Details of clinical characteristics, pathology and surgical interventions are summarised in Table 1 .
Overall, 39 surgical procedures were performed, including 25 for primary tumours and 14 for recurrences. Of the nine LEs, six procedures were performed at peripheral hospitals and three at our centre. The patient with bilateral PT had bilateral WLEs performed on her. A summary of all the surgical procedures along with recurrence rates after each procedure is provided in Table 2 . Three cases of malignant PT received adjuvant external irradiation, but none of the patients received any form of systemic therapy. Final histology was reported as benign in seven, borderline in five and malignant in 13 cases.
The median follow-up duration was 4 years (range, 1-9 years). One patient with malignant PT died due to lung metastasis at 20 months following surgery and another was lost to follow-up 15 months following surgery. At the last hospital admission, the latter patient was diagnosed as having liver and peritoneal metastases and she declined any further treatment. The rest were all alive with no evidence of disease at their last follow-up. Overall, nine (36%) cases suffered from local recurrence, and four (16%) cases experienced more than one recurrence. Overall, the median time for noticing the first recurrence was 6 months (range, 2 months to 5 years). According to histology type, the median time to recurrence was 11 months (range, 5-60 months), 5 months (range, 2-42 months) and 8.5 months (range, 4-35 months) respectively in benign, borderline and malignant PT. One patient with benign PT suffered from three recurrences before she finally underwent simple mastectomy. She was last seen 60 months following simple mastectomy and did not experience any further recurrence. In two cases, the recurrent tumours were of higher grades than the primary tumours (benign ; borderline; borderline ; malignant). In the other cases, these were of the same grades as the primary tumours.
As a primary procedure, WLE and procedures of higher magnitude were associated with no recurrence, and LE was associated with a 100% risk of recurrence. As is evident from Table 2 , irrespective of pathology type, the six patients who had WLE as their initial surgery had no recurrence in the follow-up period. Therefore, WLE seems to be an adequate primary surgical procedure for managing all PTs. However, the same does not seem to be true for recurrent tumours because 50% of such patients experienced further recurrence following WLE. None of the patients who underwent mastectomies either as primary or secondary interventions had any recurrences. Therefore, it is fair to state that patients in whom simple mastectomy is performed are unlikely to suffer from further recurrence. Clinicopathological comparison of recurrent and non-recurrent cases is provided in Table 3 . The extent of the surgical procedure was significantly associated with recurrence (p = 0.008). All cases subjected to LE had recurrence, while those who had WLE or other procedures of greater magnitude did not. Apart from this, other factors were not significantly different between the two groups. Even the type of pathology did not differ significantly between the two groups (p = 0.51).
Discussion
The clinical course of PT is unpredictable and is commonly marked by a high incidence of local recurrence and unpredictable distant metastases. 1-3 PT has a unique blend of stromal and epithelial tissue components and the stromal component predominantly determines the overall behaviour of the tumour. In order to classify the tumour as benign or malignant, numerous criteria have been proposed, and the one proposed by Azzopardi 4 and Salvadori et al 5 are widely followed. However, all the existent classifications fail in accurately predicting the clinical behaviour and outcome of PT. 6, 7 Although in most of the reported series, benign PT seems less prone to recurrence than the malignant types, it is difficult to predict recurrence in an individual case. 2 The local recurrence rate was 36% in the current study, which corresponds to the reported rate in the literature ranging from 6% to 40%. [1] [2] [3] Most of the recurrences in our patients occurred within the first year. The mean age of patients in our study group was 45 years, consistent with other reports in the literature. 2, 7, 8 Though subclassification into benign, borderline or malignant types could not be done, 72% of patients could be preoperatively diagnosed as having PT on FNAC. This rate is higher than the reported average rate in the literature, which is 12-77%. 9, 10 This fact can be attributed to the certain bias in the 24% of cases presenting with locally recurrent tumours, where there was a high degree of clinical suspicion for PT. A definite diagnosis is obviously critical for the adequate surgical management of PT. However, the diagnosis cannot be established with certainty in a significant proportion of these cases. Therefore, Jacklin et al suggested that all fibroadenoma of the breast should be considered as possible PT until proven otherwise, and if the index of suspicion is high, a core biopsy should be performed before planning the surgery. 10 This approach seems effective in preventing local recurrences but the same cannot be said about its cost effectiveness. The incidence of malignant PT among all PT cases widely varies from 1.9% to 48.2%. 2, 6 In our study, it was 52%. One possible explanation for such a disparity is that while subclassifying these tumours, different workers used different criteria. Various attempts to correlate tumour recurrence with different clinicopathological criteria have resulted in mixed outcomes. Of the various factors studied, much emphasis has been placed on tumour size and histology type. Reinfuss et al found that the histological type of PT was the only prognostic factor of the rate of recurrence in their study. The local recurrence rate in their series was 4.3%, 15.8% and 11.9% in patients with benign, borderline and malignant PT respectively. 1 Contrastingly, Bennett et al did not find any significant differences in recurrence rate among patients with benign (21%) and malignant PT (18%), 2 although they observed that malignant tumours tended to recur earlier compared to benign tumours. They also observed that tumours with infiltrating margins and large tumours were the ones likely to recur. Interestingly, in a report by Hadju et al, a higher local recurrence rate (18%) was seen in benign lesions than in malignant lesions (8%). 3 They attributed this finding to a more radical surgical procedure adopted for malignant PT as compared to their benign counterparts. This observation strengthens our own finding that irrespective of tumour characteristics, the extent of the surgical procedure is more significant in determining and/or preventing local recurrence. The long-term overall survival of patients with PT is determined by distant metastases. Metastases are mostly reported in cases with malignant and borderline tumours, and rarely in benign types. The reported incidence of distant metastases ranges from 25% to 48%. 2, 11 In our series, two patients (15%) with malignant PT developed metastases; the incidence may increase with further long-term follow-up of our cases. Surgery is the mainstay of treatment for PT. However, due to the relative rarity of the tumour, and heterogeneity of procedures applied for managing these by various centres, no definite conclusion regarding the appropriate surgical procedure can be drawn. Since PTs are rarely multifocal, WLE is currently being suggested to be an appropriate primary surgical procedure for all the histological types of PT. [1] [2] [3] Mastectomy seems to be reserved for cases where the tumour is large enough to allow a safe and cosmetically acceptable WLE procedure, although some advocate mastectomy for all malignant PTs. 2, 5 Since the incidence of axillary lymph node metastases in malignant PT is less than 0.5%, axillary lymph node dissection is not routinely recommended and rarely needed. 1, 2 No form of adjuvant therapy has been shown to be effective in preventing local recurrence and distant metastases. According to published literature, radiotherapy and chemotherapy fail to improve the clinical outcome of PT, though obviously the experience is limited and no definite conclusion can be drawn from these reports. 12, 13 Use of doxorubicin, cisplatin and etoposide have resulted in some benefit in the management of patients with visceral metastases. 14, 15 In conclusion, in our study none of the clinicopathological factors except the extent of the surgical procedure significantly affected the rate of local recurrence. WLE seemed to be an adequate initial surgical procedure for all patients with PT. Mastectomy should be reserved for recurrent or large tumours where WLE cannot be safely performed. Since recurrences are largely unpredictable, long-term follow-up of these patients is mandatory. Further collaborative studies are needed to define the exact role of adjuvant therapy in the management of malignant PT.
